CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- 8-K Event Results of operations · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4/A Grant or award Chief Financial Officer acquired 3,482 shares (grant or award)
- 4/A Grant or award Chief Operating Officer acquired 3,726 shares (grant or award)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Grant or award VP Finance and Treasurer acquired 1,503 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,334 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 3,522 shares (grant or award)
- 4 Grant or award Director acquired 2,716 shares (grant or award)
- 4 Grant or award See Remarks acquired 2,478 shares (grant or award)
- 4 Grant or award Executive Chairman acquired 12,103 shares (grant or award)
- 4 Grant or award See Remarks acquired 1,547 shares (grant or award)
- 4 Grant or award President and CEO acquired 11,699 shares (grant or award)
Page 1 of 39 · 774 filings